Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response, was established to aid in securing our nation from chemical, biological, radiological, and nuclear (CBRN) threats, as well as from pandemic influenza (PI) and emerging infectious diseases (EID). BARDA is soliciting proposals for the advanced research and development of medical countermeasures under the BARDA Broad Agency Announcement.
Proposals submitted under this BAA must focus on research and development activities that relate to specific areas of interest, consisting of medical countermeasures for chemical, biological, radiological and nuclear threats; pandemic influenza; and emerging infectious diseases. Due to the COVID-19 response, any white papers or full proposals submissions, other than those that are in support of COVID-19, will be put into a queue. Once the response to COVID-19 has subsided, we will resume normal review of submissions for other research areas of interests.
Submission in response to the BAA occurs in two stages. Stage 1 requires submitting a Quad Chart and White Paper; Stage 2 requires submitting a Full Proposal. Submission deadline is October 31, 2020.
Read the full announcement: https://beta.sam.gov/opp/1b46a4169fcb4902b9c4fcbb5bf981f7/view